Activity value 72china Supplier,Last transaction date:
2026-02-18
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for zhejiang ranto pharmaceutical indus from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 3 transactions, with a transaction quantity of 4 and a transaction weight of 7.
Product description
GABAPENTINA MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS DE USO HUMANO
Expand
Trade date
2025/12/03
B/L No.
005-2025-844397
Suppliers
zhejiang ranto pharmaceutical indus
Buyers
laboratorios cia farmaceutica l c s.a.
POLs
——
PODs
aduana santamaria
Supply area
China
Purchas area
Costa Rica
Weight
300
Amount
13200
Hs code
380700000000
Product tags
liquid smoke
Product description
PIXIDE CARBONICO LIQUIDO ALQUITRAN DE PINO SE UTILIZA PARA LA FABRICACION DE CHAMPU DE BREA MEDICADO PARA COMBATIR LA CASPA MEDICAMENTO USO HUMANO SIN MARCA
Expand
zhejiang ranto pharmaceutical indus is china Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,bat,cefaclor.
According to the 52wmb.com global trade database, as of 2026-02-18, the company has completed 44 international trades,
with its main trading regions covering india,costa rica,pakistan etc.
The core products include HS29420090,HS29419090,HS35079099 etc,
often transported via beijing etc,
and its main trading partners are nixi laboratories pvt ltd.,bharat parenterals ltd.,vardhman.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on zhejiang ranto pharmaceutical indus is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.